BIG PHARMA WATCH: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 588

Brand Name Drug Companies’ Business-as-Usual Approach to Price Increases Read More

HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 400 BRAND NAME DRUGS TO RING IN 2022

Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I

Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II

Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III

Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual Read More

SECOND OPINION: BIG PHARMA DOUBLES DOWN ON BLAME GAME STRATEGY AMID UNPRECEDENTED MOMENTUM TO LOWER RX PRICES

New PhRMA Ad Campaign Aims to Dodge Accountability, Push Pharma-Backed Rebate Read More

BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN BRAND NAME DRUGS COST U.S. $1.6 BILLION IN 2020

New Analysis Underscores How Big Pharma’s Price Increases Cost The American Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for Read More

CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS

Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Read More